Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya

Few previous studies have reported the effects of glucose-6-phosphate dehydrogenase (G6PD)–deficiency on child health in Africa. We conducted a case-control study in which cases (n = 6829) were children admitted, for any reason, to Kilifi County Hospital, Kenya, while controls (n = 10 179) were recr...

ver descrição completa

Detalhes bibliográficos
Principais autores: Uyoga, S, Macharia, AW, Ndila, CM, Nyutu, G, Shebe, M, Awuondo, KO, Mturi, N, Peshu, N, Tsofa, B, Scott, JAG, Maitland, K, Williams, TN
Formato: Journal article
Idioma:English
Publicado em: American Society of Hematology 2020
_version_ 1826272760363483136
author Uyoga, S
Macharia, AW
Ndila, CM
Nyutu, G
Shebe, M
Awuondo, KO
Mturi, N
Peshu, N
Tsofa, B
Scott, JAG
Maitland, K
Williams, TN
author_facet Uyoga, S
Macharia, AW
Ndila, CM
Nyutu, G
Shebe, M
Awuondo, KO
Mturi, N
Peshu, N
Tsofa, B
Scott, JAG
Maitland, K
Williams, TN
author_sort Uyoga, S
collection OXFORD
description Few previous studies have reported the effects of glucose-6-phosphate dehydrogenase (G6PD)–deficiency on child health in Africa. We conducted a case-control study in which cases (n = 6829) were children admitted, for any reason, to Kilifi County Hospital, Kenya, while controls (n = 10 179) were recruited from the surrounding community. Cases were subclassified based on their clinical and laboratory findings at admission. We calculated the prevalence of specific diseases by G6PD c.202 genotype, the only significant cause of G6PD-deficiency in this area, then estimated the association between genotype and admission with specific conditions using logistic regression. Among neonates, the prevalence of jaundice was higher in both G6PD c.202T heterozygotes (40/88; 45.5%; P = .004) and homo/hemizygotes (81/134; 60.5%; P < .0001) than in wild-type homozygotes (157/526; 29.9%). Median bilirubin levels also increased across the groups, being highest (239 mmol/L; interquartile range 96-390 mmol/L) in G6PD c.202T homo/hemizygotes. No differences were seen in admission hemoglobin concentrations or the prevalence of anemia or severe anemia by G6PD c.202 genotype. On case control analysis, G6PD heterozygosity was negatively associated with all-cause hospital admission (odds ratio 0.81; 95% confidence interval 0.73-0.90; P < .0001) and, specifically, admission with either pneumonia or Plasmodium falciparum parasitemia; while, conversely, it was positively associated with Gram-positive bacteremia. G6PD c.202T homo/heterozygosity was positively associated with neonatal jaundice, severe pneumonia, the receipt of a transfusion, and in-patient death. Our study supports the conclusion that G6PD c.202T is a balanced polymorphism in which a selective advantage afforded to heterozygous females against malaria is counterbalanced by increased risks of neonatal jaundice, invasive bacterial infections, and anemia.
first_indexed 2024-03-06T22:17:40Z
format Journal article
id oxford-uuid:53f66919-bbdb-4e00-a734-693cdad8a60d
institution University of Oxford
language English
last_indexed 2024-03-06T22:17:40Z
publishDate 2020
publisher American Society of Hematology
record_format dspace
spelling oxford-uuid:53f66919-bbdb-4e00-a734-693cdad8a60d2022-03-26T16:34:51ZGlucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, KenyaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:53f66919-bbdb-4e00-a734-693cdad8a60dEnglishSymplectic ElementsAmerican Society of Hematology2020Uyoga, SMacharia, AWNdila, CMNyutu, GShebe, MAwuondo, KOMturi, NPeshu, NTsofa, BScott, JAGMaitland, KWilliams, TNFew previous studies have reported the effects of glucose-6-phosphate dehydrogenase (G6PD)–deficiency on child health in Africa. We conducted a case-control study in which cases (n = 6829) were children admitted, for any reason, to Kilifi County Hospital, Kenya, while controls (n = 10 179) were recruited from the surrounding community. Cases were subclassified based on their clinical and laboratory findings at admission. We calculated the prevalence of specific diseases by G6PD c.202 genotype, the only significant cause of G6PD-deficiency in this area, then estimated the association between genotype and admission with specific conditions using logistic regression. Among neonates, the prevalence of jaundice was higher in both G6PD c.202T heterozygotes (40/88; 45.5%; P = .004) and homo/hemizygotes (81/134; 60.5%; P < .0001) than in wild-type homozygotes (157/526; 29.9%). Median bilirubin levels also increased across the groups, being highest (239 mmol/L; interquartile range 96-390 mmol/L) in G6PD c.202T homo/hemizygotes. No differences were seen in admission hemoglobin concentrations or the prevalence of anemia or severe anemia by G6PD c.202 genotype. On case control analysis, G6PD heterozygosity was negatively associated with all-cause hospital admission (odds ratio 0.81; 95% confidence interval 0.73-0.90; P < .0001) and, specifically, admission with either pneumonia or Plasmodium falciparum parasitemia; while, conversely, it was positively associated with Gram-positive bacteremia. G6PD c.202T homo/heterozygosity was positively associated with neonatal jaundice, severe pneumonia, the receipt of a transfusion, and in-patient death. Our study supports the conclusion that G6PD c.202T is a balanced polymorphism in which a selective advantage afforded to heterozygous females against malaria is counterbalanced by increased risks of neonatal jaundice, invasive bacterial infections, and anemia.
spellingShingle Uyoga, S
Macharia, AW
Ndila, CM
Nyutu, G
Shebe, M
Awuondo, KO
Mturi, N
Peshu, N
Tsofa, B
Scott, JAG
Maitland, K
Williams, TN
Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya
title Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya
title_full Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya
title_fullStr Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya
title_full_unstemmed Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya
title_short Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya
title_sort glucose 6 phosphate dehydrogenase deficiency and susceptibility to childhood diseases in kilifi kenya
work_keys_str_mv AT uyogas glucose6phosphatedehydrogenasedeficiencyandsusceptibilitytochildhooddiseasesinkilifikenya
AT machariaaw glucose6phosphatedehydrogenasedeficiencyandsusceptibilitytochildhooddiseasesinkilifikenya
AT ndilacm glucose6phosphatedehydrogenasedeficiencyandsusceptibilitytochildhooddiseasesinkilifikenya
AT nyutug glucose6phosphatedehydrogenasedeficiencyandsusceptibilitytochildhooddiseasesinkilifikenya
AT shebem glucose6phosphatedehydrogenasedeficiencyandsusceptibilitytochildhooddiseasesinkilifikenya
AT awuondoko glucose6phosphatedehydrogenasedeficiencyandsusceptibilitytochildhooddiseasesinkilifikenya
AT mturin glucose6phosphatedehydrogenasedeficiencyandsusceptibilitytochildhooddiseasesinkilifikenya
AT peshun glucose6phosphatedehydrogenasedeficiencyandsusceptibilitytochildhooddiseasesinkilifikenya
AT tsofab glucose6phosphatedehydrogenasedeficiencyandsusceptibilitytochildhooddiseasesinkilifikenya
AT scottjag glucose6phosphatedehydrogenasedeficiencyandsusceptibilitytochildhooddiseasesinkilifikenya
AT maitlandk glucose6phosphatedehydrogenasedeficiencyandsusceptibilitytochildhooddiseasesinkilifikenya
AT williamstn glucose6phosphatedehydrogenasedeficiencyandsusceptibilitytochildhooddiseasesinkilifikenya